HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 103 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $16,678,000 | +10.0% | 342,815 | -3.5% | 9.00% | +68.3% |
Q4 2021 | $15,155,000 | -33.3% | 355,415 | -40.0% | 5.35% | +18.0% |
Q3 2021 | $22,723,000 | -4.5% | 592,815 | -29.7% | 4.53% | +19.0% |
Q2 2021 | $23,793,000 | -14.6% | 842,815 | 0.0% | 3.81% | -24.0% |
Q1 2021 | $27,847,000 | -8.6% | 842,815 | 0.0% | 5.01% | -4.2% |
Q4 2020 | $30,468,000 | +6.6% | 842,815 | 0.0% | 5.23% | -42.7% |
Q3 2020 | $28,571,000 | – | 842,815 | – | 9.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Valor Management LLC | 11,218,033 | $618,113,619 | 97.50% |
venBio Partners LLC | 1,035,396 | $57,050,320 | 17.69% |
Vivo Capital, LLC | 2,606,247 | $143,604 | 16.53% |
Nan Fung Group Holdings Ltd | 368,665 | $20,313,442 | 14.00% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 264,500 | $14,560,725 | 4.50% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 685,340 | $37,762,234 | 3.51% |
ASHFORD CAPITAL MANAGEMENT INC | 356,638 | $19,650,754 | 3.05% |
TANG CAPITAL MANAGEMENT LLC | 281,200 | $15,494,120 | 2.25% |
MPM BioImpact LLC | 139,377 | $7,679,673 | 1.99% |
O'Neil Global Advisors, Inc. | 7,335 | $404 | 1.86% |